Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
HiRO Acquires U.S.-Based CRO Courante Oncology
Harvest Integrated Research Organization (HiRO) announced its acquisition of Courante Oncology, a full-service clinical research organization (CRO) based in Excelsior, Minnesota. According to data captured in the LevinPro HC database, this transaction represents the 26th CRO acquisition of the year. Courante Oncology provides clinical research consulting and services to pharmaceutical and medical device companies that are developing oncology products. HiRO is a CRO based in Shanghai, China. With global operations and integration capabilities, it provides a range of solutions and services to its clients, including early pre-clinical strategic planning, clinical trial design,... Read More »
EyeSouth Partners Acquires Retina and Vitreous of Texas
EyeSouth Partners announced on September 5 that it partnered with Retina and Vitreous of Texas, one of Houston’s leading retina-only practices. The affiliation represents EyeSouth’s thirty-eighth overall and the network’s first retina-only affiliation in the state of Texas. Financial terms of the deal were not disclosed. Retina and Vitreous of Texas has served the greater Houston market for more than 25 years, been involved in upwards of 180 medical publications and developed a nationally-renowned fellowship program that was originally established in 1997. According to its website, the practice is led by a team of six board-certified, fellowship-trained physicians. EyeSouth... Read More »
PracticeTek Merges with Integrated Practice Solutions
PracticeTek announced on September 5 that it merged with Integrated Practice Solutions (IPS) for an undisclosed price. The combined company will retain the PracticeTek brand. IPS is a retail healthcare software company, with product lines in the segments of chiropractic, optometry and speech therapies. IPS provides mission-critical practice management, electronic health record, integrated payments and revenue cycle management solutions to help specialty healthcare providers streamline operations, improve patient care and increase practice profitability. PracticeTek is a Knoxville, Tennessee-based investment firm that targets healthcare software companies. The company is backed... Read More »
LabGenomics USA Acquires QDx Pathology
LabGenomics USA announces its acquisition of Edison, New Jersey-based QDx Pathology Services. QDx Pathology Services is an independent, full-service molecular and anatomical pathology laboratory in Edison, New Jersey. The company was founded in 2006. LabGenomics USA, a subsidiary of South Korea-based LabGenomics Co., Ltd., is a healthcare company specializing in molecular diagnostics. It is based in Fountain Valley, California. The acquisition is expected to have significant implications for the future of both companies and the industry, according to the press release. The financial terms of the acquisition were not disclosed. According to data captured in... Read More »
Nestlé Divests Peanut Allergy Brand to Stallergenes Greer
Nestlé Health Science announced on September 5 its divestment of Palforzia, a children’s peanut allergy drug, to Stallergenes Greer International AG. According to data captured in the LevinPro HC database, this transaction represents the 77th Pharmaceuticals acquisition of 2023. Palforzia became the first drug approved by the FDA for peanut allergy in children in January 2020. At the time, it was projected that the drug could reach $1.28 billion in sales by 2024. Backed by B-FLEXION, Stallergenes Greer International AG is a global biopharmaceutical company. It is based in Baar, Switzerland and specializes in the diagnosis and treatment of respiratory allergies through... Read More »
VitalPoint Technologies Acquires Herban Healing
Houston-based VitalPoint Technologies, Inc. (VPT) announced on August 31 it acquired Herban Healing, LLC. The financial terms of the transaction were not disclosed. Herban Healing is a Texas-based biopharmaceutical company focused on healthcare products centered around CBD. Co-Founders Kyle Williams and Jennifer Gillelan established Herban Healing with the goal of addressing the opioid epidemic. Founded in 2019, the company operates two locations in Cypress, Texas and one in North Spring, Texas. VitalPoint Technologies was established to conduct research, develop solutions and provide education on alternative healthcare options. VPT is a tech-enabled innovative Healthcare... Read More »
MB2 Dental Solutions Expands Into 600 Locations
On August 30, MB2 Dental Solutions announced the opening of its 600th practice location, Highland Creek Family Dental – South, in Lafayette, Indiana. The practice is operated by Dr. Shane Cope, a general dentist. MB2 Dental initially partnered with Dr. Cope in August 2022 when MB2 purchased Highland Creek Family Dental. Since then, Dr. Cope was able to build a second location. MB2 Dental Solutions, a portfolio company of middle-market private equity firm Charlesbank Capital Partners since February 2021, partners with dentists and specialists. Founded in 2007, MB2 offers general dentistry services, orthodontics, cosmetic dentistry and oral surgery. According to data... Read More »
Panoramic Health Acquires Kidney Specialists of South Texas
Panoramic Health announced on August 29 its acquisition of Kidney Specialists of South Texas (KSST). KSST is a nephrology practice with two locations in Corpus Christi, Texas. According to its website, the practice has seven physicians and one nurse practitioner on staff. Panoramic Health is a physician-led kidney care organization. Panoramic Health’s Clinical Research division partners with sponsors and clinical research organizations to bring treatments to patients with kidney disease. By leveraging Panoramic Health’s integrated value-based care platform, KSST will enhance care coordination to optimize patient engagement and achieve better clinical and... Read More »
Agios Pharmaceuticals Acquires Alnylam’s siRNA Blood Disease Program
Agios Pharmaceuticals Inc. announced its acquisition of Alnylam Pharmaceuticals, Inc.’s siRNA blood disease program targeting TMPRSS6, a gene that makes protein. According to data captured in the LevinPro HC database, this transaction marks the 105th Biotechnology acquisition in 2023. Alnylam is a biopharmaceutical company focused on the discovery, development and commercialization of RNA interference therapeutics for genetically defined diseases. The company was founded in 2002. According to its most recent financial report, the company achieved net product revenues of $894 million during FY 2022. Agios is the pioneering leader in pyruvate kinase (PK) activation... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
